As controversy again heats up over rosiglitazone (Avandia), the American Diabetes Association (ADA) and American Heart Association (AHA) have stood firm on their positions on the embattled drug….
Read More »ADA: New and Novel DPP-4 Reduces HbA1c Alone and in Combination
A novel dipeptidyl peptidase 4 (DPP-4) inhibitor — linagliptin — showed improved glycemic control as monotherapy, as an add-on, and in combination with other oral diabetes medications, researchers reported….
Read More »ADA: New Insulin Dose Calculation Method Reduces Postprandial Hyperglycemia in Children
Children with Type 1 diabetes can have their pizza and eat it, too, if they calculate their premeal insulin dose according to carbohydrate, fat, and protein intake rather than carbohydrate intake alone, researchers reported….
Read More »ADA: Continuous Glucose Monitoring Only Successful with Knowledge and Support
Real-time (RT) continuous glucose monitoring (CGM) can significantly improve daytime and nighttime glucose control, but only if patients use it properly and get the right support, according to a psychologist who studies barriers to successful implementation of the technology….
Read More »ADA: Switching to Liraglutide from Exenatide Improves Glycemic Control
Conversion from exenatide to liraglutide is well tolerated and provides additional glycemic control and cardiometabolic benefits….
Read More »ADA: Inhaled Insulin Makes a Comeback for Type 2’s
In patients with Type 2 diabetes, inhaled insulin before each meal, plus insulin glargine before bedtime, is just as effective at controlling blood sugar as conventional twice-daily premixed biaspart insulin therapy, according to new research….
Read More »ADA: Exercise Alone Reduces Diabetes Risk in Obese Boys
Obese boys who engaged in regular aerobic or resistance exercise — without dietary changes — had significant improvements over 3 months in their total body fat, visceral adipose tissue concentrations, and insulin sensitivity than their more sluggish counterparts, according to the results of a randomized study….
Read More »ADA: Sensor-Augmented Insulin Pump Therapy Wins Over Multiple Daily Injections for Type 1’s
In patients with Type 1 diabetes and poor glycemic control, the use of a sensor-augmented insulin pump significantly improved their A1c levels, compared with a regimen of multiple daily insulin injections, according to a new study….
Read More »Diabetes Cure Closer to Reality
From heart transplant material to cancer therapies, pigs have provided a host of opportunities for humans, Now pigs have come to the rescue once again — this time for diabetes….
Read More »Does Tight Control of Lipids and BP Provide Benefits or Increase Harm?
Some patients with diabetes may not benefit from aggressive management of cardiovascular risk factors and some may even be harmed, according to a statistical model based on a government health survey.…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.